Compare Allstate Corp (ALL) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Allstate Corp vs Novo Nordisk A/S — how do they compare? Allstate Corp trades at $261 (market cap $66.31B), while Novo Nordisk A/S trades at $45.96 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 3.1× Allstate Corp's market cap, and Novo Nordisk A/S pays the higher dividend (3.81%). Which is the better fit depends on your goals.
| ALL | NVO | |
|---|---|---|
Market Cap | $66.31B | $207.85B |
Sector | Financials | Health |
52-Week High | $275.11 | $63.98 |
52-Week Low | $190.00 | $35.29 |
Enterprise Value | $74.96B | $222.55B |
Dividend Yield | 1.65% | 3.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Allstate Corp
On the basis of premium sales, Allstate is one of the largest U.S. property and casualty insurers. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 10,000 agencies.
Read more on ALL →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
